276 related articles for article (PubMed ID: 31425668)
1. Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
Zeng W; Wang W; Wu S; Zhu X; Zheng T; Chen X; Ren J; Gong Y; Ke M
Curr Eye Res; 2020 Feb; 45(2):190-198. PubMed ID: 31425668
[No Abstract] [Full Text] [Related]
2. Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice.
Zhu X; Wu S; Zeng W; Chen X; Zheng T; Ren J; Ke M
Front Pharmacol; 2020; 11():1006. PubMed ID: 32714192
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues.
Clark AF; Steely HT; Dickerson JE; English-Wright S; Stropki K; McCartney MD; Jacobson N; Shepard AR; Clark JI; Matsushima H; Peskind ER; Leverenz JB; Wilkinson CW; Swiderski RE; Fingert JH; Sheffield VC; Stone EM
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1769-80. PubMed ID: 11431441
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.
Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4922-33. PubMed ID: 25028360
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS
J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Patel GC; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
[TBL] [Abstract][Full Text] [Related]
7. Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells.
Liu Q; Ye Y; Lin X; Yang Y; Wu K; Yu M
Curr Eye Res; 2017 Aug; 42(8):1124-1129. PubMed ID: 28494163
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta.
Zhang X; Ognibene CM; Clark AF; Yorio T
Exp Eye Res; 2007 Feb; 84(2):275-84. PubMed ID: 17126833
[TBL] [Abstract][Full Text] [Related]
9. Autophagy in the Aging and Experimental Ocular Hypertensive Mouse Model.
Nettesheim A; Dixon A; Shim MS; Coyne A; Walsh M; Liton PB
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):31. PubMed ID: 32797200
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.
Patel GC; Phan TN; Maddineni P; Kasetti RB; Millar JC; Clark AF; Zode GS
Am J Pathol; 2017 Apr; 187(4):713-723. PubMed ID: 28167045
[TBL] [Abstract][Full Text] [Related]
11. Effect of topical Ginkgo biloba extract on steroid-induced changes in the trabecular meshwork and intraocular pressure.
Jia LY; Sun L; Fan DS; Lam DS; Pang CP; Yam GH
Arch Ophthalmol; 2008 Dec; 126(12):1700-6. PubMed ID: 19064852
[TBL] [Abstract][Full Text] [Related]
12. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
14. Relationships between Intraocular Pressure, Effective Filtration Area, and Morphological Changes in the Trabecular Meshwork of Steroid-Induced Ocular Hypertensive Mouse Eyes.
Ren R; Humphrey AA; Swain DL; Gong H
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055036
[TBL] [Abstract][Full Text] [Related]
15. Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model.
Wang F; Ma F; Song Y; Li N; Li X; Pang Y; Hu P; Shao A; Deng C; Zhang X
Eur J Pharmacol; 2020 Oct; 884():173369. PubMed ID: 32712092
[TBL] [Abstract][Full Text] [Related]
16. Identification of proteomic changes for dexamethasone-induced ocular hypertension using a tandem mass tag (TMT) approach.
Liang X; Li N; Rong Y; Wang J; Zhang H
Exp Eye Res; 2022 Mar; 216():108914. PubMed ID: 34979099
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes.
Clark AF; Wilson K; de Kater AW; Allingham RR; McCartney MD
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):478-89. PubMed ID: 7843916
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol.
Clark AF; Lane D; Wilson K; Miggans ST; McCartney MD
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):805-13. PubMed ID: 8603865
[TBL] [Abstract][Full Text] [Related]
19. Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma.
Mao W; Tovar-Vidales T; Yorio T; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8068-75. PubMed ID: 21911581
[TBL] [Abstract][Full Text] [Related]
20. Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes.
Ren R; Humphrey AA; Kopczynski C; Gong H
Invest Ophthalmol Vis Sci; 2023 Feb; 64(2):7. PubMed ID: 36734964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
